TY - JOUR
T1 - Coronavirus disease 2019 (COVID-19) vaccine breakthrough infections among healthcare personnel, December 2020–April 2021
AU - the CDC Prevention Epicenters Program
AU - Nickel, Katelin B.
AU - Fraser, Victoria J.
AU - Babcock, Hilary M.
AU - Kwon, Jennie
N1 - Funding Information:
This study was supported by the Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program (grant nos. U54CK00482 to V.J.F. and BAA 75D301-20-R-68024 contract no. 75D30121C10185 to J.H.K.). J.H.K. is also supported by the NIH National Institute of Allergy and Infectious Diseases (grant no. 1K23AI137321-01A1).
Publisher Copyright:
© The Author(s), 2022.
PY - 2022/10/13
Y1 - 2022/10/13
N2 - Coronavirus disease 2019 (COVID-19) vaccine effectiveness in the early months of vaccine availability was high among healthcare personnel (HCP) at 88.3% for 2-doses. Among those testing positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2), those with breakthrough infection after vaccination were more likely to have had a non–work-related SARS-CoV-2 exposure compared to unvaccinated HCP.
AB - Coronavirus disease 2019 (COVID-19) vaccine effectiveness in the early months of vaccine availability was high among healthcare personnel (HCP) at 88.3% for 2-doses. Among those testing positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2), those with breakthrough infection after vaccination were more likely to have had a non–work-related SARS-CoV-2 exposure compared to unvaccinated HCP.
UR - http://www.scopus.com/inward/record.url?scp=85141124309&partnerID=8YFLogxK
U2 - 10.1017/ash.2022.299
DO - 10.1017/ash.2022.299
M3 - Article
C2 - 36483397
AN - SCOPUS:85141124309
SN - 2732-494X
VL - 2
JO - Antimicrobial Stewardship and Healthcare Epidemiology
JF - Antimicrobial Stewardship and Healthcare Epidemiology
IS - 1
M1 - e169
ER -